Entera Bio Ltd.
ENTX
$1.22
$0.021.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.38M | -11.44M | -10.78M | -10.60M | -10.09M |
| Total Depreciation and Amortization | 29.00K | 30.00K | 34.00K | 37.00K | 41.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.86M | 2.78M | 2.62M | 2.65M | 2.71M |
| Change in Net Operating Assets | 432.00K | 1.26M | 1.13M | 1.26M | 980.00K |
| Cash from Operations | -9.06M | -7.37M | -7.00M | -6.66M | -6.36M |
| Capital Expenditure | -99.00K | -107.00K | -83.00K | -40.00K | -11.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -99.00K | -107.00K | -83.00K | -40.00K | -11.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 579.00K | 13.97M | 17.32M | 17.08M | 18.29M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -76.00K | -262.00K | -566.00K | -565.00K | -509.00K |
| Cash from Financing | 503.00K | 13.71M | 16.75M | 16.52M | 17.78M |
| Foreign Exchange rate Adjustments | 40.00K | 36.00K | 29.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.61M | 6.27M | 9.70M | 9.82M | 11.41M |